Literature DB >> 6343239

Comparison of the immunogenicity of vaccines prepared from viable Mycobacterium bovis BCG, heat-killed Mycobacterium leprae, and a mixture of the two for normal and M. leprae-tolerant mice.

C C Shepard, R M van Landingham, L L Walker, S Z Ye.   

Abstract

Intradermal vaccines consisting of viable Mycobacterium bovis BCG, heat-killed Mycobacterium leprae, or mixtures of the two were titrated in mice in doses of 10(5.2), 10(5.8), 10(6.4), 10(7.0), and 10(7.6) acid-fast bacilli. The immune response was measured by sensitization (48 to 72 h foot pad enlargement on challenge with 10(7.0) heat-killed M. leprae) and by protection against infection with a viable M. leprae challenge. There was increasing response with increasing dose of vaccine, and overall the responses to the three vaccines were similar. At the lowest dose, however, the combination of BCG and M. leprae gave superior protection. The local reaction to the vaccines in the lower dose range was less severe with the M. leprae vaccine. In another experiment, the three vaccines were compared in normal mice and in mice that had been rendered tolerant by intravenous injection of M. leprae. The tolerant mice developed no measurable sensitization on vaccination with M. leprae, but they developed partial but distinct sensitization on vaccination with BCG, alone or in combination with M. leprae. The tolerant mice developed little or no protection with any of the vaccines, however.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6343239      PMCID: PMC348163          DOI: 10.1128/iai.40.3.1096-1103.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  12 in total

1.  BCG vaccination of children against leprosy: seven-year findings of the controlled WHO trial in Burma.

Authors:  L M Bechelli; P G Garbajosa; M M Gyi; K Uemura; T Sundaresan; V Martínez Domínguez; M Matejka; C Tamondong; R Quagliato; V Engler; M Altmann
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

2.  B.C.G. vaccination of children against leprosy in Uganda: results at end of second follow-up.

Authors:  J A Brown; M M Stone; I Sutherland
Journal:  Br Med J       Date:  1968-01-06

3.  Immunity to Mycobacterium leprae infections in mice stimulated by M. leprae, BCG, and graft-versus-host reactions.

Authors:  C C Shepard; R Van Landingham; L L Walker
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

4.  Immunity to Mycobacterium leprae infections induced in mice by BCG vaccination at different times before or after challenge.

Authors:  C C Shepard; L L Walker; R M Van Landingham
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

5.  Heat stability of Mycobacterium leprae immunogenicity.

Authors:  C C Shepard; L L Walker; R van Landingham
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

6.  Searches among mycobacterial cultures for antileprosy vaccines.

Authors:  C C Shepard; R van Landingham; L L Walker
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

7.  Foot pad enlargement as a measure of induced immunity to Mycobacterium leprae.

Authors:  C C Shepard; F Minagawa; R Van Landingham; L L Walker
Journal:  Int J Lepr Other Mycobact Dis       Date:  1980-12

8.  BCG vaccination of children against leprosy in Uganda: final results.

Authors:  S J Stanley; C Howland; M M Stone; I Sutherland
Journal:  J Hyg (Lond)       Date:  1981-10

9.  Hereditary Characteristic that Varies Among Isolates of Mycobacterium leprae.

Authors:  C C Shepard; D H McRae
Journal:  Infect Immun       Date:  1971-01       Impact factor: 3.441

10.  Sensitization or tolerance to Mycobacterium leprae antigen by route of injection.

Authors:  C C Shepard; L L Walker; R M Van Landingham; S Z Ye
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

View more
  10 in total

1.  Enoyl-coenzyme A hydratase and antigen 85B of Mycobacterium habana are specifically recognized by antibodies in sera from leprosy patients.

Authors:  J Serafín-López; M Talavera-Paulin; J C Amador-Molina; M Alvarado-Riverón; M M Vilchis-Landeros; P Méndez-Ortega; M Fafutis-Morris; V Paredes-Cervantes; R López-Santiago; C I León; M I Guerrero; R M Ribas-Aparicio; G Mendoza-Hernández; C Carreño-Martínez; S Estrada-Parra; I Estrada-García
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

2.  Effective vaccination of mice against leprosy bacilli with subunits of Mycobacterium leprae.

Authors:  R H Gelber; P J Brennan; S W Hunter; M W Munn; J M Monson; L P Murray; P Siu; M Tsang; E G Engleman; N Mohagheghpour
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

3.  Identification of an immunostimulating protein from Mycobacterium leprae.

Authors:  N Mohagheghpour; M W Munn; R H Gelber; E G Engleman
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

4.  Induction of antigen-specific immunity and tolerance to Mycobacterium leprae in Lewis rats.

Authors:  M A Winters; R C Humphres
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

Review 5.  Treatment of leprosy in the United States.

Authors:  W R Levis
Journal:  Bull N Y Acad Med       Date:  1984-09

Review 6.  Advances and hurdles on the way toward a leprosy vaccine.

Authors:  Malcolm S Duthie; Thomas P Gillis; Steven G Reed
Journal:  Hum Vaccin       Date:  2011-11-01

7.  Vaccination of mice with a soluble protein fraction of Mycobacterium leprae provides consistent and long-term protection against M. leprae infection.

Authors:  R H Gelber; L Murray; P Siu; M Tsang
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

Review 8.  Leprosy.

Authors:  R C Hastings; T P Gillis; J L Krahenbuhl; S G Franzblau
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

9.  Vaccination with pure Mycobacterium leprae proteins inhibits M. leprae multiplication in mouse footpads.

Authors:  R H Gelber; V Mehra; B Bloom; L P Murray; P Siu; M Tsang; P J Brennan
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

10.  Vaccination of mice against Mycobacterium leprae infection.

Authors:  N B Singh; A C Lowe; R J Rees; M J Colston
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.